Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: CISPLATIN - THERAPEUTIC USE , . Treffer: 12

2014

Hofmann, H; von Haken, R; Werner, J; Kortes, N; Bergmann, F; Schemmer, P; Jäger, D; Radeleff, B; Schulze-Bergkamen, H Unresectable isolated hepatic metastases from solid pseudopapillary neoplasm of the pancreas: a case report of chemosaturation with high-dose melphalan.
Pancreatology. 2014; 14(6):546-549 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Ma, X; Rousseau, V; Sun, H; Lantuejoul, S; Filipits, M; Pirker, R; Popper, H; Mendiboure, J; Vataire, AL; Le Chevalier, T; Soria, JC; Brambilla, E; Dunant, A; Hainaut, P; IALT-Bio working group Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer.
Mol Oncol. 2014; 8(3):555-564 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2010

Voortman, J; Goto, A; Mendiboure, J; Sohn, JJ; Schetter, AJ; Saito, M; Dunant, A; Pham, TC; Petrini, I; Lee, A; Khan, MA; Hainaut, P; Pignon, JP; Brambilla, E; Popper, HH; Filipits, M; Harris, CC; Giaccone, G MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non-Small Cell Lung Carcinoma.
Cancer Res. 2010; 70(21): 8288-8298. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

2007

Filipits, M; Pirker, R; Dunant, A; Lantuejoul, S; Schmid, K; Huynh, A; Haddad, V; André, F; Stahel, R; Pignon, JP; Soria, JC; Popper, HH; Le Chevalier, T; Brambilla, E Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.
J Clin Oncol. 2007; 25(19): 2735-2740. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2006

Betticher, DC; Hsu Schmitz, SF; Tötsch, M; Hansen, E; Joss, C; von Briel, C; Schmid, RA; Pless, M; Habicht, J; Roth, AD; Spiliopoulos, A; Stahel, R; Weder, W; Stupp, R; Egli, F; Furrer, M; Honegger, H; Wernli, M; Cerny, T; Ris, HB; Swiss Group for Clinical Cancer Research (SAKK) Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study.
Br J Cancer. 2006; 94(8):1099-1106 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ugurel, S; Schadendorf, D; Pföhler, C; Neuber, K; Thoelke, A; Ulrich, J; Hauschild, A; Spieth, K; Kaatz, M; Rittgen, W; Delorme, S; Tilgen, W; Reinhold, U; Dermatologic Cooperative Oncology Group In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group.
Clin Cancer Res. 2006; 12(18):5454-5463 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Wilkinson, PM; Antonopoulos, M; Lahousen, M; Lind, M; Kosmidis, P; EPO-INT-45 Study Group Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial.
Br J Cancer. 2006; 94(7):947-954 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

2001

Reles, A; Wen, WH; Schmider, A; Gee, C; Runnebaum, IB; Kilian, U; Jones, LA; El-Naggar, A; Minguillon, C; Schönborn, I; Reich, O; Kreienberg, R; Lichtenegger, W; Press, MF Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.
Clin Cancer Res. 2001; 7(10):2984-2997 [OPEN ACCESS]
Web of Science PubMed FullText

 

2000

Klein, M; Rosen, A; Lahousen, M; Graf, AH; Rainer, A The relevance of adjuvant therapy in primary carcinoma of the fallopian tube, stages I and II: irradiation vs. chemotherapy.
Int J Radiat Oncol Biol Phys. 2000; 48(5):1427-1431
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1997

Pont, J; Bokemeyer, C; Harstrick, A; Sellner, F; Greinix, H; Stoiber, F Chemotherapy for germ cell tumors relapsing after high-dose chemotherapy and stem cell support: a retrospective multicenter study of the Austrian Study Group on Urologic Oncology.
Ann Oncol. 1997; 8(12):1229-1234
Web of Science PubMed FullText FullText_MUG

 

1990

Petru, E; Boike, G; Sevin, BU Potentiation of cisplatin cytotoxicity by methylxanthines in vitro.
J Cancer Res Clin Oncol. 1990; 116(5):431-433
Web of Science PubMed Google Scholar

 

1985

Jakse, R; Steindorfer, P; Germann, R; Kraft-Kinz, J; Hackl, A; Schneider, G; Scherlacher, A Initial results of hyperthermia in palliative therapy of cancers in the ENT area].
Laryngol Rhinol Otol (Stuttg). 1985; 64(2):52-57
Web of Science PubMed

 

© Meduni Graz Impressum